By
From the * Division of Infectious Diseases, ¶ Division of Experimental Pathology, and Department of
Immunology, Mayo Clinic, Rochester, Minnesota 55901;
Division of Infectious Diseases, Hennepin
County Medical Center, Minneapolis, Minnesota 55404; and § Immunex Corporation, Seattle,
Washington 98101
Apoptosis of bystander uninfected CD4+ T lymphocytes by neighboring HIV-infected cells is observed in cell culture and in lymphoid tissue of HIV-infected individuals. This study addresses whether antigen-presenting cells such as human macrophages mediate apoptosis of CD4+ T cells from HIV-infected individuals. Uninfected human macrophages, and to a larger degree, HIV-infected macrophages mediate apoptosis of T cells from HIV-infected, but not from uninfected control individuals. This macrophage-dependent killing targets CD4+, but not CD8+ T lymphocytes from HIV-infected individuals, and direct contact between macrophages and lymphocytes is required. Additional analyses indicated that the apoptosis-inducing ligands, FasL and tumor necrosis factor (TNF), mediate this macrophage-induced apoptosis of CD4+ T cells. These results support a role for macrophage-associated FasL and TNF in the selective depletion of CD4+ T cells in HIV-infected individuals.
The physiologic regulation of peripheral CD4+ T cell
homeostasis is influenced by the rate of lymphocyte
apoptosis. This form of cell death is tightly regulated and is
dependent upon the expression of a family of ligands (Fas
ligand [FasL], TNF, tumor necrosis factor-related apoptosisinducing ligand [TRAIL]) and receptors (Fas, TNFR) that
mediate apoptosis and upon the induction of susceptibility of
these cells to receptor-initiated apoptosis (1). Enhanced apoptosis of peripheral uninfected CD4+ T lymphocytes is
postulated to contribute to CD4+ T cell depletion in HIVinfected individuals (reviewed in references 10). Increased
spontaneous and activation-induced apoptosis of peripheral
CD4+ T cells from HIV-infected individuals is observed ex
vivo (13) and in lymph nodes of HIV-infected individuals
and SIV-infected macaques (16, 17). Importantly, a correlation between CD4+ T cell apoptosis and CD4+ T cell depletion has been established in different animal models of
AIDS (18).
Accumulating data indicate that the increased level of
CD4+ T cell apoptosis in HIV-infected individuals is due
to an aberrant upregulation of the physiological mechanisms
controlling peripheral CD4+ T cell apoptosis, namely, the
expression level of apoptosis-inducing ligands and receptors
and the state of cell susceptibility to such ligand/receptor
initiated apoptosis. Fas, FasL, TNF, and TNFR are increased in HIV-infected individuals and inversely correlated with CD4+ T cell numbers (21). In addition, peripheral CD4+ T cells from HIV-infected individuals are
highly susceptible to FasL/Fas initiated apoptosis (29, 30).
The mechanisms whereby the level of apoptosis-inducing
receptors/ligands and the state of susceptibility of CD4+ T
cells to apoptosis are increased in the context of HIV infection are unknown, although gp120 cross-linking of CD4
and tat and cytokines may be responsible as demonstrated
in vitro (31).
The circumstances whereby a susceptible CD4+ T cell
encounters apoptosis-inducing ligands remains unknown.
In vitro culture models demonstrate that uninfected CD4+
T cells undergo apoptosis upon contact by HIV-infected
cells (36, 37). Moreover, in lymph nodes from HIV-infected
individuals or SIV-infected macaques, the CD4+ T cells
that undergo apoptosis are not HIV-infected, but rather in
direct contact with neighboring HIV-infected cells (17). These observations support the requirement of direct cell
contact between a susceptible CD4+ T cell and a cell that
potentially expresses apoptosis-inducing ligands. Antigenpresenting cells such as human macrophages are postulated
to play a major role in the physiological deletion/apoptosis of activated, and hence susceptible, peripheral T lymphocytes (38) suggesting that apoptosis-inducing ligands expressed by macrophages can mediate apoptosis of susceptible CD4+ T cells. In fact, differentiated macrophages trigger
selective apoptosis of CD4+ T cells that have been rendered
susceptible following CD4+ cross-linking (39). These observations, together with the recent identification of FasL
expression in human macrophages and its upregulation by
HIV infection (40), lead to the hypothesis that antigen-presenting cells such as human macrophages may play a major
role both in normal CD4+ T cell homeostasis and in the
enhanced CD4+ T cell depletion observed in HIV-infected
individuals.
In this study, we have evaluated whether human macrophages lead to the selective apoptosis of CD4+ T cells
isolated from HIV-infected individuals. In addition, we have
analyzed whether apoptosis-inducing ligands presumably present on human macrophages participate in the apoptosis
of CD4+ T cells. Our results demonstrate that human macrophages induce selective apoptosis of CD4+ T lymphocytes from HIV-infected individuals through FasL and TNF.
Patient Population and Isolation of Peripheral Blood Mononuclear
Cells.
HIV-infected individuals attending the HIV Clinics at
Hennepin County Medical Center (Minneapolis, MN) and Mayo
Clinic (Rochester, MN) were selected based on CD4+ T lymphocyte counts of >100 cells/dl and absence of concomitant opportunistic infections. After obtaining informed consent, 50 ml
of whole blood was obtained and PBMC were isolated by density gradient centrifugation (Ficoll Hypaque; Pharmacia LKB Biotechnology, Inc., Piscataway, NJ). Cells were then cultured in
RPMI 1640 supplemented with 10% AB serum (GIBCO BRL,
Gaithersburg, MD) and adhered to plastic at 37°C in 5% CO2 for
two 1 h periods. The nonadherent cells (PBL) were pelleted and
resuspended in RPMI 1640 10% FBS (Hyclone Laboratories Inc.,
Logan, UT) at a final concentration of 1 × 106 cells/ml.
Viral Stocks and HIV Infection.
Supernatants from cultures of
PHA-IL2-treated PBMC either infected or not with HIV-SF162
(obtained from National Institutes of Health AIDS Reference and
Reagent Program) were collected at days 6 through 10 after infection. Clarified and filtered supernatants were analyzed for p24
content using a commercial ELISA kit (Cellular Products Inc.,
Buffalo, NY), and mycoplasma using a commercial RIA kit
(Fisher, Pittsburgh, PA). Supernatants were then aliquoted and
stored at 120°C.
Antibodies and Fusion Proteins. Anti-Fas monoclonal antibodies M3 and M33 were used to determine the involvement of Fas/ FasL interaction. M3 and M33 bind to Fas, but M3 and not M33 blocks ligand induced killing (2, 5, 40). Fusion proteins containing the Fc portion of mouse IgG1 and the Fas antigen (Fas-Fc), the TNFR (TNFRFc), or CD40 (CD40-Fc) have been previously described (40, 41).
Determination of Apoptosis in CD4+ or CD8+ T Lymphocytes. Apoptosis was measured using a flow cytometric method previously described (29, 41). PBL were washed in RPMI 10% AB serum (GIBCO BRL), and resuspended in PBS 0.1% azide. Cells were then incubated for 15 min at 4°C with 1 µg/106 cells of both FITC-labeled anti-CD3 monoclonal antibody (Becton Dickinson, San Jose, CA) and PE-conjugated anti-CD4 monoclonal antibody (CALTAG Labs., South San Francisco, CA) in the presence of 0.01% sodium azide. Hoechst 33342 (2 µg/ml) (Calbiochem Corp., La Jolla, CA) was added, and cells were incubated for an additional 7 min at 4°C. Cells were then washed and resuspended in ice-cold 0.5% paraformaldehyde in PBS. Flow cytometric evaluation was performed using a FACSTAR+® flow cytometer. 30,000 events were recorded and apoptosis was separately quantitated in the CD4+ and CD8+ populations. Apoptotic cells were quantitated by gating on cells with decreased forward angle light scatter and increased Hoechst-specific fluorescence.
Coincubation of Macrophages and PBLs. Unless stated, 5 × 106 HIV- or mock-infected MDM/well in 24-well plates were washed and incubated for 36 h with 106 PBL from HIV seropositive or seronegative individuals. In experiments addressing cell- cell contact, 6.5 mm transwell porous cell culture inserts (0.4 µm) (Costar) were placed into wells containing HIV- or mock-infected MDM. PBL were added to the top of the transwell.
In experiments addressing the role of autologous killing of PBLs by HIV-infected MDMs, the methodology was as follows. 200 cc of peripheral blood was obtained and MDMs were cultured, HIV infected, and reseeded as above. In the case of the HIV seronegative individual, 9 d after HIV infection of the MDMs, an additional 50 ml of peripheral blood was obtained, and PBLs were isolated and cultured in media containing PHA (Murex Wellcome, Research Triangle Park, NC) at 10 µg/ml and IL-2 (Hoffmann-LaRoche, Nutley, NJ) at 60 IU/ml to generate lymphoblasts. 14 d after HIV infection of MDM, an additional 50 ml of peripheral blood was drawn from the same individual and PBLs were isolated. PHA and IL-2 blasts or freshly isolated PBLs were then incubated with HIV-infected MDMs in the presence or absence of M3 or M33 Fab antibodies for 24 h. PBL blasts, but not freshly isolated PBLs, from the HIV seronegative individual, were shown to be Fas sensitive as demonstrated by the induction of apoptosis by cross-linked agonist anti-Fas antibody (M3), but not by isotype matched control antibody. In experiments addressing syngeneic apoptosis of CD4+ T cells in an HIV-infected individual, MDMs were isolated from 300 cc of peripheral blood from this individual and HIV infected in vitro. 14 d after HIV infection of MDM, PBLs were isolated and coincubated with HIV-MDM in the presence or absence of M3 or M33 Fab antibodies for 24 h.Statistical Analysis. Comparison of the amount of apoptosis that was observed with different HIV seropositive or seronegative PBL donors after coincubation with either uninfected or HIV-infected macrophages were made using a one way analysis of variance.
To determine whether MDM
trigger apoptosis of CD4+ T cells, 14-d-old MDM from
HIV seronegative healthy donors were incubated for 36 h
with freshly isolated PBL from HIV-infected individuals or
HIV seronegative healthy donors. Thereafter, nonadherent
cells were harvested and analyzed using flow cytometry to
detect apoptosis within CD4+ or CD8+ T lymphocytes. A
representative example of this analysis is depicted in Fig. 1 A. A minimal degree of CD4+ T cell apoptosis (median of
1.25%) is observed in PBL from HIV seronegative healthy
control donors (Fig. 1 B). However, when MDM are incubated with PBL from HIV-infected individuals, a larger degree of CD4+ T lymphocyte apoptosis is observed (median
of 8.7%, P = 0.039) (Fig. 1 C), suggesting enhanced susceptibility of CD4+ T cells from HIV-infected individuals
to MDM-mediated apoptosis.
Previous studies in lymph nodes from HIV-infected individuals indicate that those cells that are undergoing apoptosis are not HIV-infected, but are in direct contact with HIV-infected ones (17). Therefore, we tested whether HIV infection of MDM further enhances the MDM-mediated CD4+ T cell apoptosis in PBL from HIV-infected individuals. Using the same experimental design as described above, PBL from HIV seronegative healthy controls and from HIVinfected individuals were incubated with 14-d-old HIVinfected MDM. A significant increase in CD4+ T cell apoptosis is observed in PBL from HIV-infected individuals incubated with HIV-MDM (median 16.1%) as compared to the degree of CD4+ T cell apoptosis in PBL from HIV seronegative individuals (median 4.2%, compare Fig. 1, E and D, P = 0.001). In addition, HIV-infected MDM, as compared to uninfected ones, further increase the apoptosis of CD4+ T cells from HIV seronegative individuals (compare Fig. 1 D with B, P = 0.025) and HIV-infected individuals (compare Fig. 1, E with C, P = 0.001).
Altogether, these results indicate that uninfected, and to a larger degree, HIV-infected MDM selectively induce apoptosis of CD4+ T cells, and that CD4+ T cells from HIV seropositive individuals are inherently more susceptible to MDM and HIV-MDM-mediated apoptosis.
MDM Trigger Apoptosis of CD4+, but not CD8+, T Lymphocytes.Because CD4+ T lymphocytes are preferentially
depleted over CD4+ T cells in HIV-infected individuals,
we sought to determine whether MDM induced apoptosis of
T lymphocytes is restricted to CD4+ T cells. For this, PBL
from five different HIV seropositive individuals (HIV-PBL)
were incubated with HIV-infected MDM (HIV-MDM) at
different effector (HIV-MDM) to target (HIV-PBL) ratios.
After 36 h of coincubation, PBLs were analyzed using flow
cytometry to determine the level of apoptosis with CD4+
and CD8+ T cells. Spontaneous apoptosis was higher in
CD8+ than CD4+ T cells (Fig. 2). Increasing the effector
to target ratio resulted in a progressive increase in the level
of CD4+ T cell apoptosis in all patients, an effect that was
not observed in CD8+ T lymphocytes from the same HIVinfected individual (Fig. 2). These results indicate that
MDM can trigger selective apoptosis of susceptible CD4+
T lymphocytes.
Cell Contact Is Required for HIV-MDM-mediated Apoptosis of CD4+ T cells from HIV-infected Individuals.
Human macrophages express apoptosis-inducing ligands such as FasL and
TNF (40, 42). Because these two apoptosis-inducing ligands
may participate in CD4+ T cell apoptosis and are known to
be expressed in both cell-associated and soluble form (21),
we investigated whether direct cell contact between MDM
and PBL is required for CD4+ T cell apoptosis. HIV- or
mock-infected MDM were coincubated with PBL from
another series of five HIV-infected individuals, in the presence or absence of transwells. Apoptosis of CD4+ T cells
was then analyzed by flow cytometry. CD4+ T cell apoptosis mediated by mock-infected MDM (NI) was decreased in the presence of transwells in all patients tested (Fig. 3, compare lanes 1 and 2). Similarly, the higher level of
CD4+ T cell apoptosis mediated by HIV-infected MDM
(HIV) was also decreased in the presence of transwells (Fig.
3, compare lanes 3 and 4). These results support the requirement for direct contact between MDM and PBL to
result in the selective apoptosis of CD4+ T cells from HIVinfected individuals.
Fas/FasL Interactions Participate in the Apoptosis of CD4+ T cells from HIV Seropositive Individuals Triggered by HIVMDM.
We have previously described that FasL is partly
responsible for the HIV-MDM-mediated apoptosis of Fas
susceptible targets such as Jurkat T cells and PHA-IL2-
treated T cell blasts (40). Based on the above results, we questioned whether HIV-MDM triggered apoptosis of CD4+ T
cells from HIV seropositive individuals is mediated through FasL/Fas interactions. PBL from a series of 18 HIV-infected
individuals were incubated with HIV-infected MDM (HIVMDM). The role of FasL was analyzed by adding blocking
(M3 Fab) or nonblocking (M33 Fab
) anti-Fas antibodies
to wells in which MDM-HIV and PBL were coincubated.
In a subgroup of patients (patients No. 1-8), Fas blocking
antibodies (M3) completely reversed the CD4+ T cell apoptosis triggered by MDM-HIV (Fig. 4 A). However, in additional patients, M3 incompletely reversed CD4+ T cell
apoptosis (patients No. 9-14) or had no effect (patients No.
15-18). In those patient samples in which M3 blocked
HIV-MDM triggered apoptosis, the nonblocking M33 had
no effect. From these results, it is inferred that apoptosis of
CD4+ T cells from HIV-infected individuals triggered by
HIV-infected MDM is partially mediated by FasL.
The above experiments were performed under allogeneic conditions in which MDM, obtained from healthy HIV seronegative individuals and infected in vitro with HIV, were coincubated with freshly isolated allogeneic PBLs from a series of HIV-infected individuals. While FasL/Fas interactions are presumed to be unaffected by allo-antigens, we performed additional experiments to address this issue. First, we determined whether lymphocyte blasts that were generated by incubating PBL from an HIV seronegative individual with PHA and IL-2, would become apoptotic upon incubation with syngeneic HIV-MDM. It has been previously demonstrated that PHA-IL-2-treated lymphocytes become susceptible to FasL-dependent apoptosis (40). In addition, we tested whether FasL/Fas interactions participated in the MDM-HIV-triggered apoptosis of syngeneic lymphocyte blasts. As shown in Fig. 4 B (left), HIVMDMs increased the spontaneous level of apoptosis of syngeneic CD4+ T cell blasts, an effect that was reversed by anti-Fas blocking (M3) but not nonblocking (M33) antibodies. The susceptibility of lymphocyte blasts to FasL was confirmed by their coincubation with cross-linked anti-Fas antibodies (see legend Fig. 4 B). This suggests that the HIV-MDM-mediated, FasL-dependent, apoptosis of susceptible CD4+ T cells can also be observed in a syngeneic model. These observations were confirmed using MDM and PBL obtained from an HIV seropositive individual. MDM were HIV infected in vitro and coincubated 14 d later with freshly isolated PBL. As shown in Fig. 4 B (right), HIV-infected MDMs enhanced the level of spontaneous apoptosis of freshly isolated CD4+ T lymphocytes, an effect that was reduced by anti-Fas blocking (M3), but not by nonblocking (M33) Fab antibodies. These results suggest that the enhanced FasL-dependent apoptosis of CD4+ T cells of this HIV-infected individual is also observed using syngeneic HIV-infected MDM.
TNF Participates in the MDM-triggered Apoptosis of CD4+ T cells from HIV Seropositive Individuals.TNF is present as
a soluble or cell membrane bound form (6), is produced by
macrophages (42), and, as for FasL, can cause apoptosis of
activated T cells (8, 9). To determine whether TNF participates in the apoptosis of CD4+ T lymphocytes mediated
by MDM, PBLs from five HIV-infected individuals were
coincubated with uninfected and HIV-infected MDM for
48 h in the presence or absence of the human TNFRFc fusion protein. This incubation period was selected to allow
for possible differences in the timing of induction of T
lymphocyte apoptosis by FasL and TNF (9). In parallel, we
tested possible additive or synergistic effects between TNF
and FasL using FasFc fusion proteins. As shown in Fig. 5,
FasFc inhibited the HIV-MDM induced apoptosis of CD4+
T lymphocytes from the five HIV-infected individuals
(compare lanes 2 and 3). However, TNFRFc also reduced
CD4+ T cell apoptosis from the same individuals to a similar degree to that observed with FasFc (compare lanes 2-4).
Interestingly, combining of TNFRFc and FasFc resulted in
an additive inhibition of HIV-MDM mediated apoptosis of
CD4+ T cells (lane 5). CD40Fc, included to control for the
specificity of fusion protein dependent inhibition, reduced
the MDM-mediated apoptosis of CD4+ T cells in three
patients, albeit to a lower degree than FasFc or TNFRFc
(lane 6). Altogether, these results indicate that FasL and
TNF participate in the selective apoptosis of CD4+ T cells
from HIV-infected individuals mediated by human macrophages.
This report provides evidence of a cellular interaction that selectively mediates CD4+ T cell apoptosis of HIVinfected, but not uninfected, individuals. This finding is noteworthy in several regards. First, macrophage-induced apoptosis is selective for CD4+ T lymphocytes. Second, HIV infection of macrophages further enhances CD4+ T cell apoptosis from HIV-infected individuals. Third, CD4+ T cells from HIV-infected individuals are inherently more susceptible to macrophage-derived apoptosis-triggering ligands, including FasL and TNF.
A large number of studies addressing apoptosis of PBL from HIV-infected individuals have demonstrated that ex vivo activation of PBL from HIV-infected individuals results in enhanced CD4+, but also CD8+ T cell apoptosis (14, 15, 18, 32, 43), hence raising doubts about the relevance of this observation to the in vivo CD4+ T cell depletion observed in HIV-infected individuals. Our results indicate that macrophage-PBL interactions do not further enhance the spontaneous apoptosis of CD8+ T cells, but selectively increases CD4+ T cell apoptosis. This in vitro finding may be of relevance to the pathogenesis of HIV where selective CD4+ T cell depletion is observed, and which correlates with animal models of AIDS where ex vivo apoptosis of PBL is primarily enhanced within CD4+ T cells (18). It is possible that differences in susceptibility to macrophage-bearing apoptosis-inducing ligands (FasL and TNF) between CD4+ and CD8+ T cells account for such selectivity. Alternatively, the frequency or affinity of the interaction between macrophages and CD4+ T cells is higher than between macrophages and CD8+.
If interactions between macrophages and susceptible CD4+ T cells participate in CD4+ T cell depletion in HIV-infected individuals, uninfected MDM may suffice to mediate apoptosis of susceptible CD4+ T cells, and thus not depend solely on the apoptosis-inducing capabilities of HIVinfected macrophages. Alveolar macrophages from HIVinfected individuals are highly activated (potentially expressing apoptosis-inducing ligands) (44). While the role of these macrophages in AIDS pathogenesis is unknown, their presence correlates with decreased CD4+ T cells in alveolar fluid (49), thus suggesting that organs with high lymphocyte toxicity such as the lung may be involved in CD4+ T cell depletion via macrophage-lymphocyte interactions.
In other organs such as lymphoid tissue, uninfected antigen-presenting cells but also HIV-infected macrophages, can participate in further enhancing apoptosis of susceptible CD4+ T cells. Studies from lymph nodes indicate a bystander effect in the apoptosis of uninfected cells by HIVinfected neighboring cells (17); thus, future studies should characterize the type of HIV-infected cell that interacts with susceptible bystander CD4+ T cells. The key role of HIV-infected macrophages in causing CD4+ T cell depletion is inferred from hu-SCID HIV mouse models. Mosier et al. demonstrated that monocytotropic viruses resulted in enhanced and accelerated apoptosis of the repopulated CD4+ T cell population, suggesting that macrophages might play an important role in CD4+ T cell depletion upon HIV infection (50). The enhanced FasL-dependent apoptosis of freshly isolated CD4+ T lymphocytes from HIV-infected individuals triggered by HIV-infected MDM is most likely a result of enhanced FasL expression or synthesis. However, the possibility that CD4+ T cells become infected during the 24-36-h incubation period with HIV-MDM cannot be completely excluded. The fact that uninfected MDM also induce FasL-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals, albeit to a lower degree than HIV-infected MDMs, points to macrophage-related mechanisms. Moreover, HIV infection of MDM increases the RNA steady state levels of FasL, and this correlates with increased apoptosis of susceptible target cells through FasL-dependent mechanisms (40). Lastly, fixing of HIVinfected MDMs does not abrogate the selective apoptosis of CD4+ susceptible T lymphocytes (40). The percentage of HIV-infected MDM, as detected by intracytoplasmic p24 (which may overestimate the number of HIV-infected cells by taking into account that MDM can phagocytize p24), was variable in each experiment, reflecting donor variability and macrophage susceptibility to HIV infection. This variability of HIV infection may have impacted the range of apoptosis observed. Additional studies are in progress to determine whether HIV-infected macrophages and/or uninfected macrophages present in the HIV-infected culture is/are responsible for the enhanced apoptosis of susceptible CD4+ T lymphocytes by FasL or TNF. Additional studies should also focus on determining which of the different subpopulations present within MDM cultures express functional apoptotic-inducing ligands.
Macrophages are thought to play a role in the physiological CD4+ T cell depletion in healthy individuals (38). Our results support this observation, and point to macrophages as having a major role in FasL-dependent apoptosis of susceptible CD4+ T cells from HIV-infected patients (29, 30). The state of activation, and thus of susceptibility, of the CD4+ T cell, and not the state of differentiation or HIV infection of the macrophage, may be the critical factor regulating CD4+ T cell apoptosis. Abundant data supports that CD4+ T cells from HIV-infected individuals, even at early stages of the disease, are highly activated (51, 52). Although the mechanism(s) leading to aberrant T cell activation in HIV-infected individuals remain unknown, they may be related to the degree of viral load. Decreases in viral load correlates with decreased CD4+ T cell depletion (53, 54). If HIV-dependent mechanisms result in CD4+ T cell activation and potential susceptibility to apoptosis, reductions of viral load should decrease the state of T cell activation and hence susceptibility to apoptosis.
Characterization of the molecules responsible for inducing apoptosis of CD4+ T cells from HIV-infected individuals is important to advance our knowledge of the cause of CD4+ T cell depletion. The participation of FasL in mediating the apoptosis triggered by MDM was not unexpected based on the recent identification of FasL in MDM (40) and the observed enhanced susceptibility to FasL in PBL from HIV-infected individuals (29). However, it was surprising to observe that TNF could also play a role in inducing apoptosis of CD4+ T lymphocytes from HIV-infected individuals. Recent studies indicate that Fas ligand triggers apoptosis of T lymphocytes earlier than TNF (9). Although we did not address this time sequence in our experimental design, MDMs and CD4+ T lymphocytes were coincubated for 48 h so that the potential effect of both apoptotic inducing ligands could be detected. The role of TNF as an apoptotic inducing ligand in macrophages may be relevant to HIV pathogenesis. Increased TNF and TNFR levels are observed in HIV-infected individuals and correlate with CD4+ T cell depletion (26, 27), and our results suggest that this receptor/ligand family may play a key role in directly causing CD4+ T cell apoptosis. Such prediction is supported by the recent observation that TNF, aside from FasL, is partially responsible for activation-induced T lymphocyte apoptosis in animal models (9, 29), and that antigen-induced apoptosis of CD4+ T cells from HIV-infected individuals may be mediated by TNF (55). Our results also indicate that while Fas ligand and TNF appear to be the major mediators of apoptosis of CD4+ T lymphocytes by MDMs, in a small number of patients, additional MDMmediated apoptosis independent from TNF and/or Fas ligand was observed. This suggests that other ligands known to induce apoptosis may play a role. TRAIL (Apo-2L) is a new member of the TNF family with apoptotic inducing capability (7, 55). Likewise, lymphotoxin has also been recently suggested to play a role in the apoptosis of CD4+ T lymphocytes from HIV-infected individuals (56). Based on this, additional experiments should determine whether any of these two ligands participate in MDM-induced apoptosis of CD4+ T lymphocytes from HIV-infected individuals.
Although our study was aimed at identifying basic mechanisms that participate in the enhanced apoptosis of CD4+ T cells, their relevance to HIV pathogenesis needs to be validated in clinical studies. Correlation of viral load and CD4+ T cell number with susceptibility of CD4+ T cells to FasL and TNF needs to be established. Level and localization of the expression of these ligands in lymphoid tissue and organs from HIV-infected individuals also needs to be addressed. Characterization of the mechanisms that lead to enhanced susceptibility to lymphocyte apoptosis and the abnormal regulation of apoptosis-inducing ligands in HIVinfected patients would allow future therapeutical interventions to reduce or control virus-dependent enhanced CD4+ T cell depletion.
Address correspondence to Dr. Carlos V. Paya, Division of Infectious Diseases, Mayo Clinic, 200 First Street SW, Guggenheim 501, Rochester, MN 55905.
Received for publication 14 August 1996
We would like to acknowledge the excellent secretarial assistance of Mr. Douglas Hauschild.1. | Krammer, P.H., I. Behrmann, P. Daniel, J. Dhein, and K.-M. Debatin. 1994. Regulation of apoptosis in the immune system. Curr. Opin. Immunol. 6: 279-289 [Medline] . |
2. | Alderson, M.R., T.W. Tough, S. Braddy, T. Davis, Smith, E. Roux, K. Schooley, R.E. Miller, and D.H. Lynch. 1994. Regulation of apoptosis and T cell activation by Fas-specific mAb. Int. Immunol. 6: 1799-1806 [Abstract] . |
3. | Dhein, J., H. Walczak, C. Bäumler, K.-M. Debatin, and P.H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature (Lond.). 373: 438-441 [Medline] . |
4. | Brunner, T., R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverri, S.J. Martin, W.R. Force, D.H. Lynch, C.F. Ware, and D.R. Green. 1995. Cell-autonomous Fas (CD95)/Fasligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (Lond.). 373: 441-444 [Medline] . |
5. | Alderson, M.R., T.W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K.A. Schooley, R.G. Goodwin, C.A. Smith, F. Ramsdell, and D.H. Lynch. 1995. Fas ligand mediates activationinduced cell death in human T lymphocytes. J. Exp. Med. 181: 71-77 [Abstract] . |
6. | Smith, C.A., T. Farrah, and R.G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 76: 959-962 [Medline] . |
7. | Wiley, S.R., K. Schooley, P.J. Smolak, W.S. Din, C.-P. Huang, J.K. Nicholl, G.R. Sutherland, T.D. Smith, D. Rauch, C.A. Smith, and R.G. Goodwin. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 3: 673-682 [Medline] . |
8. | Sytwu, H.-K., R.S. Liblau, and H.O. McDevitt. 1996. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity. 5: 17-30 [Medline] . |
9. | Zheng, L., G. Fisher, R.E. Miller, J. Peschon, D.H. Lynch, and M.J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature (Lond.). 377: 348-351 [Medline] . |
10. | Finkel, T.H., and N.K. Banda. 1994. Indirect mechanisms of HIV pathogenesis: how does HIV kill T cells. Curr. Opin. Immunol. 6: 605-615 [Medline] . |
11. | Ameisen, J.C.. 1994. Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer. AIDS (Phila.). 8: 1197-1213 . |
12. | Oyaizu, N., and S. Pahwa. 1995. Role of apoptosis in HIV disease pathogenesis. J. Clin. Immunol. 15: 217-231 [Medline] . |
13. | Gougeon, M.-L., S. Garcia, J. Heeney, R. Tschopp, H. Lecoeur, D. Guetard, V. Rame, C. Dauguet, and L. Montagnier. 1993. Programmed cell death in AIDS-related HIV and SIV infection. AIDS Res. Hum. Retroviruses. 9: 553-563 [Medline] . |
14. | Groux, H., G. Torpier, D. Monté, Y. Mouton, A. Capron, and J.C. Ameisen. 1992. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus- infected asymptomatic individuals. J. Exp. Med. 175: 331-340 [Abstract] . |
15. | Meyaard, L., S.A. Otto, R.R. Jonker, M.J. Mijnster, R.P.M. Keet, and F. Miedema. 1992. Programmed death of T cells in HIV-1 infection. Science (Wash. DC). 257: 217-219 [Medline] . |
16. |
Muro-Cacho, C.A.,
G. Pantaleo, and
A.S. Fauci.
1995.
Analysis of apoptosis in lymph nodes of HIV-infected persons.
J.
Immunol.
154:
5555-5566
|
17. | Finkel, T.H., G. Tudor-Williams, N.K. Banda, M.F. Cotton, T. Curiel, C. Monks, T.W. Baba, R.M. Ruprecht, and A. Kupfer. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIVinfected lymph nodes. Nat. Med. 1: 129-134 [Medline] . |
18. |
Estaquier, J.,
T. Idziorek,
F. De Bels,
F. Barré-Sinoussi,
B. Hurtrel,
A.-M. Aubertin,
A. Venet,
M. Mehtali,
E. Muchmore,
P. Michel, et al
.
1994.
Programmed cell death and
AIDS: significance of T-cell apoptosis in pathogenic and
nonpathogenic primate lentiviral infections.
Proc. Natl. Acad.
Sci. USA.
91:
9431-9435
|
19. | Johnson, B.K., G.A. Stone, M.S. Godec, D.M. Asher, D.C. Gajdusek, and C.J. Gibbs Jr.. 1993. Long-term observations of human immunodeficiency virus-infected chimpanzees. AIDS Res. Hum. Retroviruses. 9: 375-378 [Medline] . |
20. | Heeney, J., R. Jonker, W. Koornstra, R. Dubbes, N. Niphuis, A.M. Di Rienzo, M.L. Gougeon, and L. Montagnier. 1993. The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J. Med. Primatol. 22: 194-200 [Medline] . |
21. | Tanaka, M., T. Suda, T. Takahashi, and S. Nagata. 1995. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO (Eur. Mol. Biol. Organ.) J. 14: 1129-1135 [Abstract] . |
22. | Aries, S.P., B. Schaaf, C. Müller, R.H. Dennin, and K. Dalhoff. 1995. Fas (CD95) expression on CD4+ T cells from HIV-infected patients increases with disease progression. J. Mol. Med. 73: 591-593 [Medline] . |
23. | Silvestris, F., P. Cafforio, M.A. Frassanito, M. Tucci, A. Romito, S. Nagata, and F. Dammacco. 1996. Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis. AIDS (Phila.). 10: 131-141 . |
24. | Gehri, R., S. Hahn, M. Rothen, M. Steuerwald, R. Nuesch, and P. Erb. 1996. The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells. AIDS (Phila.). 10: 9-16 . |
25. | Mitra, D., M. Stainer, D.H. Lynch, L. Staiano-Coico, and J. Laurence. 1996. HIV-1 upregulates Fas ligand on CD4+ T cells in vitro and in vivo: association with Fas-mediated apoptosis. Immunology. 87: 581-585 [Medline] . |
26. |
Bilello, J.A.,
K. Stellrecht,
G.L. Drusano, and
D.S. Stein.
1996.
Soluble tumor necrosis factor-![]() ![]() |
27. |
Macchia, D.,
F. Almerigogna,
P. Parronchi,
A. Ravina,
E. Maggi, and
S. Romagnani.
1993.
Membrane tumour necrosis
factor-![]() |
28. | Debatin, K.-M., and A. Fahrig-Faissner. 1994. High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood. 83: 3101-3103 [Medline] . |
29. | Katsikis, P.D., E.S. Wunderlich, C.A. Smith, L.A. Herzenberg, and L.A. Herzenberg. 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181: 2029-2036 [Abstract] . |
30. | Estaquier, J., T. Idziorek, W. Zou, D. Emilie, C.-M. Farber, J.-M. Bourez, and J.C. Ameisen. 1995. T helper type1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J. Exp. Med. 182: 1759-1767 [Abstract] . |
31. | Banda, N.K., J. Bernier, D.K. Kurahara, R. Kurrle, N. Haigwood, R.-P. Sekaly, and T.H. Finkel. 1992. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176: 1099-1106 [Abstract] . |
32. | Oyaizu, N., T.W. McCloskey, M. Coronesi, N. Chirmule, V.S. Kalyanaraman, and S. Pahwa. 1993. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood. 82: 3392-3400 [Abstract] . |
33. | Cohen, D.I., Y. Tani, H. Tian, E. Boone, L.E. Samelson, and C. Lane. 1992. Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1. Science (Wash. DC). 256: 542-545 [Medline] . |
34. | Laurent-Crawford, A.G., B. Krust, Y. Riviére, C. Desgranges, S. Muller, M.P. Kieny, C. Hauguet, and A.G. Hovanessian. 1993. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res. Hum. Retroviruses. 9: 761-773 [Medline] . |
35. | Westendorp, M.O., R. Frank, O. Ochsenbauer, K. Strickler, J. Dhein, H. Walczak, K.M. Debatin, and P.H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 tat and gp120. Nature (Lond.). 375: 497-500 [Medline] . |
36. | Heinkelein, M., S. Sopper, and C. Jassoy. 1995. Contact of human immunodeficiency virus type 1-infected and uninfected CD4+ T lymphocytes is highly cytolytic for both cells. J. Virol. 69: 6925-6931 [Abstract] . |
37. | Nardelli, B., C.J. Gonzalez, M. Schechter, and F.T. Valentine. 1995. CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. Proc. Natl. Acad. Sci. USA. 92: 7312-7316 [Abstract] . |
38. | Munn, D.H., J. Pressey, A.C. Beall, R. Hudes, and M.R. Alderson. 1996. Selective activation-induced apoptosis of peripheral T cells imposed by macrophages. J. Immunol. 156: 523-532 [Abstract] . |
39. | Wu, M.X., J.F. Daley, R.A. Rasmussen, and S.F. Schlossman. 1995. Monocytes are required to prime peripheral blood T cells to undergo apoptosis. Proc. Natl. Acad. Sci. USA. 92: 1525-1529 [Abstract] . |
40. | Badley, A.D., J.A. McElhinny, P.J. Leibson, D.H. Lynch, M.R. Alderson, and C.V. Paya. 1996. Upregulation of Fas ligand expression by HIV in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70: 199-206 [Abstract] . |
41. |
McElhinny, J.A.,
W.S. MacMorran,
G.D. Bren,
R.M. Ten,
A. Israel, and
C.V. Paya.
1995.
Regulation of IkB![]() |
42. | Gendelman, H.E., J.M. Orenstein, L.M. Baca, B. Weiser, H. Burger, D.C. Kalter, and M.S. Meltzer. 1989. The macrophage in the persistence and pathogenesis of HIV infection. AIDS (Phila.). 3: 475-495 . |
43. | Gougeon, M.-L., S. Garcia, J. Heeney, R. Tschopp, H. Lecoeur, D. Guetard, V. Rame, C. Dauguet, and L. Montagnier. 1993. Programmed cell death in AIDS-related HIV and SIV infection. AIDS Res. Hum. Retroviruses. 9: 553-563 [Medline] . |
44. | Agostini, C., R. Zambello, L. Trentin, S. Garbisa, P.F. Di Celle, P. Bulian, M. Onisto, V. Poletti, L. Spiga, E. Raise, et al . 1991. Alveolar macrophages from patients with AIDS and AIDS-related complex constitutively synthesize and release tumor necrosis factor alpha. Am. Rev. Respir. Dis. 144: 195-201 [Medline] . |
45. |
Israël-Biet, D.,
J. Cadranel,
K. Beldjord,
J.-M. Andrieu,
A. Jeffrey, and
P. Even.
1991.
Tumor necrosis factor production
in HIV-seropositive subjects.
J. Immunol.
147:
490-494
|
46. | Trentin, L., S. Garbisa, R. Zambello, C. Agostini, C. Caenazzo, C. Di Francesco, A. Cipriani, E. Francavilla, and G. Semenzato. 1992. Spontaneous production of interleukin-6 by alveolar macrophages from human immunodeficiency virus type 1-infected patients. J. Infect. Dis. 166: 731-737 [Medline] . |
47. |
Twigg, H.L. III,
G.K. Iwamoto, and
D.M. Soliman.
1992.
Role of cytokines in alveolar macrophage accessory cell function in HIV-infected individuals.
J. Immunol.
149:
1462-1469
|
48. |
Buhl, R.,
H.A. Jaffe,
K.J. Holroyd,
Z. Borok,
J.H. Roum,
A. Mastrangeli,
F.B. Wells,
M. Kirby,
C. Saltini, and
R.G. Crystal.
1993.
Activation of alveolar macrophages in asymptomatic HIV-infected individuals.
J. Immunol.
150:
1019-1028
|
49. | Wasserman, K., M. Subklewe, G. Pothoff, N. Banik, and E. Schell-Frederick. 1994. Expression of surface markers on alveolar macrophages from symptomatic patients with HIV infection as detected by flow cytometry. Chest. 105: 1324-1334 [Abstract] . |
50. | Mosier, D.E., R.J. Gulizia, A. MacIsaac, B.E. Torbett, and J.A. Levy. 1993. Rapid loss of CD4+ T cells in human-PBLSCID mice by noncytopathic HIV isolates. Science (Wash. DC). 260: 689-692 [Medline] . |
51. | Fauci, A.S.. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science (Wash. DC). 262: 1011-1018 [Medline] . |
52. | Ascher, M.S., and H.W. Sheppard. 1990. AIDS as immune system activation. II. The panergic imnesia hypothesis. J. Acquired Immune Defic. Syndr. 3: 177-191 [Medline] . |
53. | Ho, D.D., A.U. Neumann, A.S. Perelson, W. Chen, J.M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (Lond.). 373: 123-126 [Medline] . |
54. | Wei, X., S.K. Ghosh, M.E. Taylor, V.A. Johnson, E.A. Emini, P. Deutsch, J.D. Lifson, S. Bonhoeffer, M.A. Nowak, B.H. Hahn, et al . 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (Lond.). 373: 117-122 [Medline] . |
55. |
Pitti, R.M.,
S.A. Marsters,
S. Ruppert,
C.J. Donahue,
A. Moore, and
A. Ashkenazi.
1996.
Induction of apoptosis by
APO-2 ligand. A new member of the tumor necrosis factor
cytokine family.
J. Biol. Chem.
271:
12687-12690
|
56. | Clerici, M., A. Sarin, J.A. Berzofsky, A.L. Landay, H.A. Kessler, F. Hashemi, C.W. Hendrix, S.P. Blatt, J. Rusnak, M.J. Dolan, et al . 1996. Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin. AIDS (Phila.). 10: 603-611 . |